Follow
Cancer Therapeutics
Cancer Therapeutics: Cancer is often treated by surgery, chemotherapy, radiation therapy, targeted therapy (including immunotherapy such as monoclonal antibody therapy), hormonal therapy, and synthetic lethality. The choice of therapy depends upon the stage of the disease, and the location and grade of the tumor, as well as the patient's general status. Many clinical trial cancer treatments are also under development.
-
APR 07, 2016 | 9:00 AM
Pathology departments are under significant pressure to meet the demands of a precise medicine environment where general phenotypic attributes are no longer sufficient for accurately defining...APR 07, 2016 | 7:30 AM
Oncologists and pathologists are increasingly utilizing information on genomic alterations in tumors to help guide patient care and treatment. Personalis, Inc., a genomic sequencing and inter...APR 07, 2016 | 6:00 AM
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...FEB 24, 2016 | 1:00 PM
Precision medicine requires understanding the mechanistic basis of complex disorders, and to precisely manipulate these mechanisms to better human health. This is partly enabled by the recent...FEB 24, 2016 | 11:00 AM
Cell death is involved in diseases such as cancer and neurodegeneration, and also has a natural role in the development of multicellular organisms. Although apoptosis has been well defined, a...FEB 24, 2016 | 10:00 AM
Every day, vast amounts of healthcare data are collected from clinical trials as well as real world medical visits on patient treatment regimens and subsequent clinical outcomes. This big dat...FEB 02, 2016 | 9:00 AM
DATE: February 2nd, 2016 TIME: 9am pacific time, 12pm eastern time What is the most appropriate technology to empower your research? Next generation sequencing (NGS) for RN...Speaker: Sridar Chittur, PhD, MBA , Yesim Gökmen-Polar, PhDSponsored By: Affymetrix, AffymetrixJAN 20, 2016 | 8:00 AM
Over the past decade, there has been a rapid growth in studies of secreted membrane vesicles, collectively called extracellular vesicles (EVs). (1) The release of EVs has been reported in the...Speaker: Vasilis Toxavidis , John TiggesPresented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life SciencesNOV 11, 2015 | 6:00 AM
Next-generation sequencing has emerged as a valuable tool for generating patient-specific genetic information for clinical diagnostics and optimal selection of targeted therapies. The heterog...Speaker: Christina (Tina) Lockwood, PhD, DABCC, FACBNOV 04, 2015 | 11:00 AM
DATE: November 4th, 2015 TIME: 11:00am Pacific time, 2:00pm Eastern time AMPK, a highly conserved sensor of cellular energy status, is found in all eukaryotic cells and maintains met...OCT 01, 2015 | 12:00 PM
The 95% failure rate of anticancer therapeutic being approved after positive Phase III trials suggests that existing pre-clinical approaches and tools are inadequate predictors of clinical ou...OCT 01, 2015 | 7:30 AM
Melanoma, a cancer of pigment-producing cells, accounts for nearly 200,000 new cases of cancer reported each year worldwide. It is the deadliest skin cancer. Alarmingly, in the U.S., the inci...Speaker: Louise Perkins, PhDOCT 01, 2015 | 7:30 AM
While TDM is routinely used in a number of medical fields, it has not gained wide utilization in oncology. There is a growing body of evidence demonstrating that current dosing methods based...Speaker: Salvatore Salamone, PhDSEP 30, 2015 | 1:30 PM
Biomarkers, with their associated “tsunami” of publications, represent what is arguably one of the largest areas of scientific inquiry in the history of biomedicine. Touted as the...SEP 30, 2015 | 12:00 PM
Hepatocellular carcinoma (HCC) is a significant contributor to cancer-related mortality in the United States and worldwide. Current treatments are largely ineffective: single agent and combin...SEP 30, 2015 | 9:00 AM
The Warburg effect or aerobic glycolysis is a well-known cancer metabolism phenomenon and serves as an established test for tumor detection with FDG-PET scanning technology. Cancer cells swit...Speaker: Jennifer Molina, PhDSEP 30, 2015 | 7:30 AM
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...SEP 30, 2015 | 7:30 AM
The landscape for treatment options in metastatic castration resistant prostate cancer has changed dramatically since 2010. There have been more therapies approved since 2010 than in the prio...Speaker: Lawrence Karsh MD FACSSEP 30, 2015 | 6:00 AM
LEARNING OBJECTIVES:1. Enhanced audience understanding regarding the controversy surrounding prostate cancer screening using the PSA blood test and use of the American Uro...Speaker: Judd W Moul, MD, FACSSEP 02, 2015 | 6:00 AM
Among many surprising insights, the genomic revolution has helped us to realize that we're never alone and, in fact, barely human. For most of our lives, we share our bodies with some ten ti...SEP 02, 2015 | 6:00 AM
Human microbiome projects have delivered our first glimpse into the microbial communities that reside in and on our bodies. Building on these efforts the research community has begun to corre...JUN 17, 2015 | 8:00 AM
DATE: June 17th, 2015TIME: 8am Pacific time, 11am Eastern timeSpatial heterogeneity of tumors has been identified within and between metastatic lesions and can be visualized wit...MAY 14, 2015 | 1:30 PM
Asthma is heritable, influenced by the environment, and is modified by in utero exposures and aging; all of these features are also common to epigenetic regulation. Furthermore, genetic varia...MAY 14, 2015 | 1:30 PM
Germline cancer genetics became a reality with the cloning of the tumor suppressor gene RB1 for hereditary retinoblastoma in 1986 by Friend and Weinberg. The existence of cancer susceptibili...
APR 07, 2016 | 9:00 AM
Pathology departments are under significant pressure to meet the demands of a precise medicine environment where general phenotypic attributes are no longer sufficient for accurately defining...
APR 07, 2016 | 7:30 AM
Oncologists and pathologists are increasingly utilizing information on genomic alterations in tumors to help guide patient care and treatment. Personalis, Inc., a genomic sequencing and inter...
APR 07, 2016 | 6:00 AM
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...
FEB 24, 2016 | 1:00 PM
Precision medicine requires understanding the mechanistic basis of complex disorders, and to precisely manipulate these mechanisms to better human health. This is partly enabled by the recent...
FEB 24, 2016 | 11:00 AM
Cell death is involved in diseases such as cancer and neurodegeneration, and also has a natural role in the development of multicellular organisms. Although apoptosis has been well defined, a...
FEB 24, 2016 | 10:00 AM
Every day, vast amounts of healthcare data are collected from clinical trials as well as real world medical visits on patient treatment regimens and subsequent clinical outcomes. This big dat...
FEB 02, 2016 | 9:00 AM
DATE: February 2nd, 2016
TIME: 9am pacific time, 12pm eastern time
What is the most appropriate technology to empower your research?
Next generation sequencing (NGS) for RN...
Speaker:
Sridar Chittur, PhD, MBA
, Yesim Gökmen-Polar, PhD
Sponsored By: Affymetrix,
Affymetrix
JAN 20, 2016 | 8:00 AM
Over the past decade, there has been a rapid growth in studies of secreted membrane vesicles, collectively called extracellular vesicles (EVs). (1) The release of EVs has been reported in the...
Speaker:
Vasilis Toxavidis
, John Tigges
Presented at: Beckman Coulter Life Sciences Virtual Trade Show
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
NOV 11, 2015 | 6:00 AM
Next-generation sequencing has emerged as a valuable tool for generating patient-specific genetic information for clinical diagnostics and optimal selection of targeted therapies. The heterog...
Speaker:
Christina (Tina) Lockwood, PhD, DABCC, FACB
NOV 04, 2015 | 11:00 AM
DATE: November 4th, 2015
TIME: 11:00am Pacific time, 2:00pm Eastern time
AMPK, a highly conserved sensor of cellular energy status, is found in all eukaryotic cells and maintains met...
OCT 01, 2015 | 12:00 PM
The 95% failure rate of anticancer therapeutic being approved after positive Phase III trials suggests that existing pre-clinical approaches and tools are inadequate predictors of clinical ou...
OCT 01, 2015 | 7:30 AM
Melanoma, a cancer of pigment-producing cells, accounts for nearly 200,000 new cases of cancer reported each year worldwide. It is the deadliest skin cancer. Alarmingly, in the U.S., the inci...
Speaker:
Louise Perkins, PhD
OCT 01, 2015 | 7:30 AM
While TDM is routinely used in a number of medical fields, it has not gained wide utilization in oncology. There is a growing body of evidence demonstrating that current dosing methods based...
Speaker:
Salvatore Salamone, PhD
SEP 30, 2015 | 1:30 PM
Biomarkers, with their associated “tsunami” of publications, represent what is arguably one of the largest areas of scientific inquiry in the history of biomedicine. Touted as the...
SEP 30, 2015 | 12:00 PM
Hepatocellular carcinoma (HCC) is a significant contributor to cancer-related mortality in the United States and worldwide. Current treatments are largely ineffective: single agent and combin...
SEP 30, 2015 | 9:00 AM
The Warburg effect or aerobic glycolysis is a well-known cancer metabolism phenomenon and serves as an established test for tumor detection with FDG-PET scanning technology. Cancer cells swit...
Speaker:
Jennifer Molina, PhD
SEP 30, 2015 | 7:30 AM
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...
SEP 30, 2015 | 7:30 AM
The landscape for treatment options in metastatic castration resistant prostate cancer has changed dramatically since 2010. There have been more therapies approved since 2010 than in the prio...
Speaker:
Lawrence Karsh MD FACS
SEP 30, 2015 | 6:00 AM
LEARNING OBJECTIVES:1. Enhanced audience understanding regarding the controversy surrounding prostate cancer screening using the PSA blood test and use of the American Uro...
Speaker:
Judd W Moul, MD, FACS
SEP 02, 2015 | 6:00 AM
Among many surprising insights, the genomic revolution has helped us to realize that we're never alone and, in fact, barely human. For most of our lives, we share our bodies with some ten ti...
SEP 02, 2015 | 6:00 AM
Human microbiome projects have delivered our first glimpse into the microbial communities that reside in and on our bodies. Building on these efforts the research community has begun to corre...
JUN 17, 2015 | 8:00 AM
DATE: June 17th, 2015TIME: 8am Pacific time, 11am Eastern timeSpatial heterogeneity of tumors has been identified within and between metastatic lesions and can be visualized wit...
MAY 14, 2015 | 1:30 PM
Asthma is heritable, influenced by the environment, and is modified by in utero exposures and aging; all of these features are also common to epigenetic regulation. Furthermore, genetic varia...
MAY 14, 2015 | 1:30 PM
Germline cancer genetics became a reality with the cloning of the tumor suppressor gene RB1 for hereditary retinoblastoma in 1986 by Friend and Weinberg. The existence of cancer susceptibili...